Assessment on Treatments With Conventional Synthetic Disease-modifying Drugs Before Initiating Biologics in Patients With Rheumatoid Arthritis in Korea: A Population-based Study

OBJECTIVE: To assess pre-biologic treatments with conventional synthetic disease-modifying drugs (csDMARDs) prior to biologics initiation among patients with rheumatoid arthritis (RA). METHODS: Using Korea National Health Insurance database, we examined pre-biologic treatments of RA patients on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Min Jung, Park, Eun Hye, Shin, Anna, Ha, You-Jung, Lee, Yun Jong, Lee, Eun Bong, Baek, Han Joo, Kang, Eun Ha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Rheumatology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351359/
https://www.ncbi.nlm.nih.gov/pubmed/37475897
http://dx.doi.org/10.4078/jrd.2022.29.2.79

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351359/
https://www.ncbi.nlm.nih.gov/pubmed/37475897
http://dx.doi.org/10.4078/jrd.2022.29.2.79

Ejemplares similares